Dynamin 2 and c-Abl Are Novel Regulators of Hyperoxia-mediated NADPH Oxidase Activation and Reactive Oxygen Species Production in Caveolin-enriched Microdomains of the Endothelium*
暂无分享,去创建一个
J. Garcia | V. Natarajan | P. Singleton | N. Mambetsariev | Joe G. N. Garcia | J. Moitra | S. Pendyala | I. Gorshkova
[1] Yutong Zhao,et al. Phospholipase D-mediated Activation of IQGAP1 through Rac1 Regulates Hyperoxia-induced p47phox Translocation and Reactive Oxygen Species Generation in Lung Endothelial Cells* , 2009, Journal of Biological Chemistry.
[2] M. Gougerot-Pocidalo,et al. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases , 2009, Experimental & Molecular Medicine.
[3] A. Klibanov,et al. Akt-Mediated Transactivation of the S1P1 Receptor in Caveolin-Enriched Microdomains Regulates Endothelial Barrier Enhancement by Oxidized Phospholipids , 2009, Circulation research.
[4] V. Natarajan,et al. Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins. , 2009, Antioxidants & redox signaling.
[5] V. Natarajan,et al. Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells. , 2009, Antioxidants & redox signaling.
[6] H. Schmidt,et al. NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. , 2008, Pharmacology & therapeutics.
[7] A. Sirvent,et al. Cytoplasmic signalling by the c‐Abl tyrosine kinase in normal and cancer cells , 2008, Biology of the cell.
[8] R. Arlinghaus,et al. Activated c-Abl tyrosine kinase in malignant solid tumors , 2008, Oncogene.
[9] J. M. Robinson. Reactive oxygen species in phagocytic leukocytes , 2008, Histochemistry and Cell Biology.
[10] A. T. Lau,et al. Reactive oxygen species: Current knowledge and applications in cancer research and therapeutic , 2008, Journal of cellular biochemistry.
[11] C. Schwencke,et al. The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium. , 2008, Journal of molecular and cellular cardiology.
[12] S. Ryter,et al. Deletion of caveolin-1 protects against oxidative lung injury via up-regulation of heme oxygenase-1. , 2008, American journal of respiratory cell and molecular biology.
[13] G. Hu,et al. Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[14] R. Salgia,et al. CD44 Regulates Hepatocyte Growth Factor-mediated Vascular Integrity , 2007, Journal of Biological Chemistry.
[15] W. Sessa,et al. Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice , 2007, The Journal of experimental medicine.
[16] S. Dudek,et al. Regulation of Hyperoxia-induced NADPH Oxidase Activation in Human Lung Endothelial Cells by the Actin Cytoskeleton and Cortactin* , 2007, Journal of Biological Chemistry.
[17] M. Lisanti,et al. Caveolae and caveolin-1: novel potential targets for the treatment of cardiovascular disease. , 2007, Current pharmaceutical design.
[18] D. Gutterman,et al. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. , 2007, American journal of physiology. Heart and circulatory physiology.
[19] R. Parton,et al. The multiple faces of caveolae , 2007, Nature Reviews Molecular Cell Biology.
[20] Shwu-Fan Ma,et al. Transactivation of Sphingosine 1-Phosphate Receptors Is Essential for Vascular Barrier Regulation , 2006, Journal of Biological Chemistry.
[21] T. Mayadas,et al. Vav Proteins in Neutrophils Are Required for FcγR-Mediated Signaling to Rac GTPases and Nicotinamide Adenine Dinucleotide Phosphate Oxidase Component p40(phox)1 , 2006, The Journal of Immunology.
[22] M. Ushio-Fukai. Localizing NADPH Oxidase–Derived ROS , 2006, Science's STKE.
[23] Simon J. Walker,et al. NADPH oxidases in cardiovascular health and disease. , 2006, Antioxidants & redox signaling.
[24] S. Ryu,et al. The phox homology domain of phospholipase D activates dynamin GTPase activity and accelerates EGFR endocytosis , 2006, Nature Cell Biology.
[25] M. McNiven,et al. Dynamin as a mover and pincher during cell migration and invasion , 2006, Journal of Cell Science.
[26] Zhen-Yu Chen,et al. Reactive oxygen species in vascular wall. , 2006, Cardiovascular & hematological disorders drug targets.
[27] R. Alexander,et al. cAbl Tyrosine Kinase Mediates Reactive Oxygen Species– and Caveolin-Dependent AT1 Receptor Signaling in Vascular Smooth Muscle: Role in Vascular Hypertrophy , 2005, Circulation research.
[28] A. Shah,et al. NADPH oxidase and endothelial cell function. , 2005, Clinical science.
[29] R. Alexander,et al. Caveolin-1 Is Essential for Activation of Rac1 and NAD(P)H Oxidase After Angiotensin II Type 1 Receptor Stimulation in Vascular Smooth Muscle Cells: Role in Redox Signaling and Vascular Hypertrophy , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[30] N. Parinandi,et al. Src-mediated Tyrosine Phosphorylation of p47phox in Hyperoxia-induced Activation of NADPH Oxidase and Generation of Reactive Oxygen Species in Lung Endothelial Cells* , 2005, Journal of Biological Chemistry.
[31] M. McNiven,et al. Caveolin-1 interacts directly with dynamin-2. , 2005, Journal of molecular biology.
[32] Xiang-An Li,et al. Caveolae, lipid rafts, and vascular disease. , 2005, Trends in cardiovascular medicine.
[33] D. Schafer. Regulating Actin Dynamics at Membranes: A Focus on Dynamin , 2004, Traffic.
[34] A. Malik,et al. Role of Src-induced Dynamin-2 Phosphorylation in Caveolae-mediated Endocytosis in Endothelial Cells* , 2004, Journal of Biological Chemistry.
[35] L. Bourguignon,et al. CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation. , 2004, Experimental cell research.
[36] M. Lisanti,et al. The Caveolin genes: from cell biology to medicine , 2004, Annals of medicine.
[37] Nicole Rusk,et al. Modulation of Rac localization and function by dynamin. , 2003, Molecular biology of the cell.
[38] Oliver Hantschel,et al. Regulation of the c-Abl and Bcr–Abl tyrosine kinases , 2004, Nature Reviews Molecular Cell Biology.
[39] E. Schiffrin,et al. c-Src Induces Phosphorylation and Translocation of p47phox: Role in Superoxide Generation by Angiotensin II in Human Vascular Smooth Muscle Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[40] C. Mastick,et al. c-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14. , 2003, Cellular signalling.
[41] J. Zweier,et al. Viswanathan Natarajan Cells Regulation by Map Kinases in Human Lung Endothelial Hyperoxia-induced Nad(p)h Oxidase Activation And , 2002 .
[42] L. Stephens,et al. Regulation of Phosphatidylinositol 3-Kinase Activity and Phosphatidylinositol 3,4,5-Trisphosphate Accumulation by Neutrophil Priming Agents1 , 2002, The Journal of Immunology.
[43] Giulio Superti‐Furga,et al. c‐Abl is an effector of Src for growth factor‐induced c‐myc expression and DNA synthesis , 2002, The EMBO journal.
[44] R. Weichselbaum,et al. Activation of the Cytoplasmic c-Abl Tyrosine Kinase by Reactive Oxygen Species* , 2000, The Journal of Biological Chemistry.
[45] A. Kazlauskas,et al. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. , 1999, Genes & development.
[46] Seymour Reichlin,et al. Handbook of experimental pharmacology , 1984 .